Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:15 AM
Ignite Modification Date:
2025-12-25 @ 11:24 PM
NCT ID:
NCT02542293
Group ID:
EG002
Title:
China: Durvalumab + Tremelimumab
Description:
Participants received durvalumab 20 mg/kg and tremelimumab 1 mg/kg IV infusion Q4W in combination for up to 4 doses/cycles. Participants then continued to receive durvalumab 20 mg/kg Q4W, starting on Week 16 until objective PD, initiation of alternative anticancer therapy, unacceptable toxicity, withdrawal of consent, or specific treatment discontinuation criteria were met.
Deaths Number Affected:
50
Deaths Number At Risk:
None
Serious Number Affected:
32
Serious Number At Risk:
77
Other Number Affected:
73
Other Number At Risk:
77
Study:
NCT02542293
Results Section:
NCT02542293
Adverse Events Module:
NCT02542293